In a chapter in the newly released GCR Insight: Europe, Middle East and Africa Antitrust Review 2020, Antitrust/Competition partners James Killick, Assimakis Komninos and Axel Schulz and local partners Jérémie Jourdan and Strati Sakellariou-Witt cover the main developments in the pharmaceutical sector in the European Union over the period May 2018-April 2019. To view the chapter, click here.
The chapter is an extract from GCR's Europe, Middle East and Africa Antitrust Review 2020, first published in July 2019. The whole publication is available at globalcompetitionreview.com/edition/1001354/europe-middle-east-and-africa-antitrust-review-2020
See also: United States: Pharmaceutical Antitrust 2020
This publication is provided for your convenience and does not constitute legal advice. This publication is protected by copyright.
